Research letterLack of efficacy of topical timolol for cutaneous telangiectasias in patients with hereditary hemorrhagic telangiectasia: Results of a pilot study
References (5)
Topical timolol for the treatment of epistaxis in hereditary hemorrhagic telangiectasia
Am J Otolaryngol
(2012)- et al.
Topical application of timolol decreases the severity and frequency of epistaxis in patients who have previously undergone nasal dermoplasty for hereditary hemorrhagic telangiectasia
Auris Nasus Larynx
(2016)
There are more references available in the full text version of this article.
Cited by (5)
Hereditary hemorrhagic telangiectasia: from signaling insights to therapeutic advances
2024, Journal of Clinical InvestigationTopical beta-blockers in dermatologic therapy
2021, Dermatologic TherapyThe role of topical timolol in wound healing and the treatment of vascular lesions: A narrative review
2021, Dermatologic TherapyThe role of β-blockers in dermatological treatment: a review
2018, Journal of the European Academy of Dermatology and Venereology
Funding sources: None.
Conflicts of interest: None declared.
© 2016 by the American Academy of Dermatology, Inc.